SCHEMBL24964657

SCHEMBL24964657

c1cc(-c2ccc(N(c3ccc(-c4ccc5oc6ccccc6c5c4)cc3)c3ccccc3-c3ccc4c(c3)oc3ccccc34)cc2)cc(-c2ccc3ccccc3c2)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HCRTR1 O43613 1/20 0.35
▸ PLA2G2A P14555 3/20 0.35
▸ PLA2G4A P47712 3/20 0.35
▸ PLA2G10 O15496 1/20 0.35
▸ ALOX5 P09917 1/20 0.34
▸ CASP3 P42574 1/20 0.33
▸ SENP7 Q9BQF6 1/20 0.33
▸ SENP6 Q9GZR1 1/20 0.33
▸ ANO1 Q5XXA6 1/20 0.33
▸ MMP12 P39900 1/20 0.33
▸ MMP13 P45452 1/20 0.33
▸ HSP90AA1 P07900 1/20 0.33
▸ HSP90AB1 P08238 1/20 0.33
▸ PRKDC P78527 2/20 0.32
▸ AHR P35869 2/20 0.32
▸ KDM4E B2RXH2 2/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ MAPT P10636 2/20 0.32
▸ HPGD P15428 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23232749 1.00 HCRTR1 (0.35) HCRTR1PLA2G2APLA2G4APLA2G10ALOX5
SCHEMBL23233597 0.97 HCRTR1 (0.35) HCRTR1PLA2G2APLA2G4APLA2G10ALOX5
SCHEMBL23232750 0.97 PLA2G2A (0.34) HCRTR1PLA2G2APLA2G4APLA2G10ALOX5
SCHEMBL23233099 0.97 HCRTR1 (0.37) HCRTR1PLA2G2APLA2G4APLA2G10ALOX5
SCHEMBL24964608 0.97 HCRTR1 (0.37) HCRTR1PLA2G2APLA2G4AALOX5CASP3
SCHEMBL23231785 0.97 HCRTR1 (0.37) HCRTR1PLA2G2APLA2G4AALOX5CASP3
SCHEMBL24964093 0.97 PLA2G2A (0.37) PLA2G2APLA2G4APLA2G10ALOX5CASP3
SCHEMBL23231765 0.97 HCRTR1 (0.37) HCRTR1PLA2G2APLA2G4AALOX5CASP3
SCHEMBL24964610 0.97 HCRTR1 (0.37) HCRTR1PLA2G2APLA2G4AALOX5CASP3
SCHEMBL23180923 0.96 HCRTR1 (0.37) HCRTR1PLA2G2APLA2G4APLA2G10ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230026162-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026162-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE L1CAM, LEF1, MLX HCRTR1 3134/4885PLA2G2A 3282/4885PLA2G4A 3577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback